Tick-Borne Disease Antibodies Panel with Reflexes

Tick-Borne Disease Antibodies Panel with Reflexes

Test Code

16220
86618, 86666 (x4), 86753 (x2)
16220
86618, 86666 (x4), 86753 (x2)
In-home collection may be available in your area for purchase through Quest Mobile.

Clinical Significance

Tick-Borne Disease Antibodies Panel with Reflexes - This panel contains components for the detection of antibodies against Borrelia burgdorferi (Lyme disease) using the modified two-tier algorithm, Anaplasma phagocytophilum, Ehrlichia chaffeensis, and Babesia microti. Infection with these organisms can occur from the bite of a tick found in endemic regions, including the upper Northeast and Midwestern United States. Appropriate reflex testing of individual components is performed for initial screen results.

The tests included in the panel are serologic assays used to aid in the diagnosis of select tickborne related ...

Test Details

Includes

  • Lyme Disease Antibody with Reflex to Immunoassay (IgG, IgM) (MTTT)
    Anaplasma phagocytophilum Antibodies (IgG, IgM) with Reflex to Titer
    Babesia microti Antibodies (IgG, IgM) with Reflex to Titers
    Ehrlichia chaffeensis Antibodies (IgG, IgM) with Reflex to Titers

    If Lyme Disease Antibody is Positive or Equivocal (≥0.90), then Lyme Disease Supplemental Antibodies (IgG, IgM), Immunoassay will be performed at an additional charge (CPT code(s): 86617(x2)).

    If A. phagocytophilum (IgG) is Detected, then A. phagocytophilum (IgG) Titer will be performed at an additional charge (CPT code(s): 86317).
    If A. phagocytophilum (IgM) is Detected, then A. phagocytophilum (IgM) Titer will be performed at an additional charge (CPT code(s): 86317).

    If Babesia microti (IgG) is Detected, then Babesia microti (IgG) Titer will be performed at an additional charge (CPT code(s): 86317).
    If Babesia microti (IgM) is Detected, then Babesia microti (IgM) Titer will be performed at an additional charge (CPT code(s): 86317).

    If E. chaffeensis (IgG) is Detected, then E. chaffeensis (IgG) Titer will be performed at an additional charge (CPT code(s): 86317).
    If E. chaffeensis (IgM) is Detected, then E. chaffeensis (IgM) Titer will be performed at an additional charge (CPT code(s): 86317).

Methodology

See individual tests

Assay Category

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Reference Range(s)

Lyme Ab, Screen<0.90 index
A. phagocytophilum Ab (IgG), ScreenNot Detected
A. phagocytophilum Ab (IgM), ScreenNot Detected
Babesia microti Ab (IgG), ScreenNot Detected
Babesia microti Ab (IgM), ScreenNot Detected
E. chaffeensis Ab (IgG), ScreenNot Detected
E. chaffeensis Ab (IgM), ScreenNot Detected
   
   Lyme Ab (IgG)<0.90 index
   Lyme Ab (IgM)<0.90 index
   A. phagocytophilum Ab (IgG), Titer<1:64 titer
   A. phagocytophilum Ab (IgM), Titer<1:20 titer
   Babesia microti Ab (IgG), Titer<1:64 titer
   Babesia microti Ab (IgM), Titer<1:20 titer
   E. chaffeensis Ab (IgG), Titer<1:64 titer
   E. chaffeensis Ab (IgM), Titer<1:20 titer

Alternative Name(s)

Anaplasma Phagocytophilum Ab,Babesia Microti Antibodies,Ehrlichia Chaffeensis Ab,Lyme Disease Ab w/Refl

LOINC® Codes, Performing Laboratory

Lyme Disease Antibody with Reflex to Immunoassay (IgG, IgM) (MTTT)
Anaplasma phagocytophilum Antibodies (IgG, IgM) with Reflex to Titer
Babesia microti Antibodies (IgG, IgM) with Reflex to Titers
Ehrlichia chaffeensis Antibodies (IgG, IgM) with Reflex to Titers

If Lyme Disease Antibody is Positive or Equivocal (≥0.90), then Lyme Disease Supplemental Antibodies (IgG, IgM), Immunoassay will be performed at an additional charge (CPT code(s): 86617(x2)).

If A. phagocytophilum (IgG) is Detected, then A. phagocytophilum (IgG) Titer will be performed at an additional charge (CPT code(s): 86317).
If A. phagocytophilum (IgM) is Detected, then A. phagocytophilum (IgM) Titer will be performed at an additional charge (CPT code(s): 86317).

If Babesia microti (IgG) is Detected, then Babesia microti (IgG) Titer will be performed at an additional charge (CPT code(s): 86317).
If Babesia microti (IgM) is Detected, then Babesia microti (IgM) Titer will be performed at an additional charge (CPT code(s): 86317).

If E. chaffeensis (IgG) is Detected, then E. chaffeensis (IgG) Titer will be performed at an additional charge (CPT code(s): 86317).
If E. chaffeensis (IgM) is Detected, then E. chaffeensis (IgM) Titer will be performed at an additional charge (CPT code(s): 86317).

Methodology

See individual tests
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Reference Range(s)

Lyme Ab, Screen<0.90 index
A. phagocytophilum Ab (IgG), ScreenNot Detected
A. phagocytophilum Ab (IgM), ScreenNot Detected
Babesia microti Ab (IgG), ScreenNot Detected
Babesia microti Ab (IgM), ScreenNot Detected
E. chaffeensis Ab (IgG), ScreenNot Detected
E. chaffeensis Ab (IgM), ScreenNot Detected
   
   Lyme Ab (IgG)<0.90 index
   Lyme Ab (IgM)<0.90 index
   A. phagocytophilum Ab (IgG), Titer<1:64 titer
   A. phagocytophilum Ab (IgM), Titer<1:20 titer
   Babesia microti Ab (IgG), Titer<1:64 titer
   Babesia microti Ab (IgM), Titer<1:20 titer
   E. chaffeensis Ab (IgG), Titer<1:64 titer
   E. chaffeensis Ab (IgM), Titer<1:20 titer

Alternative Name(s)

Anaplasma Phagocytophilum Ab,Babesia Microti Antibodies,Ehrlichia Chaffeensis Ab,Lyme Disease Ab w/Refl

Preferred Specimen(s)

2 mL serum

Minimum Volume

1.5 mL

Transport Container

Transport tube

Transport Temperature

Refrigerated (cold packs)

Specimen Stability

  • Room temperature: 72 hours
    Refrigerated: 7 days
    Frozen: 30 days

Setup Schedule

2 mL serum
1.5 mL
Transport tube
Refrigerated (cold packs)
Room temperature: 72 hours
Refrigerated: 7 days
Frozen: 30 days
In-home collection may be available in your area for purchase through Quest Mobile.
Test Details

Clinical Significance

Test Resources

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.

The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.